Varian's Embozene Is an FDA Breakthrough - Physical Therapy Products

Varian announces that the US Food and Drug Administration (FDA) has granted the company Breakthrough Device Designation for its Embozene microspheres for genicular artery embolization (GAE) for symptomatic knee osteoarthritis.

Related Keywords

Siemens Healthineers , Frank Facchini , Siddharth Padia , Santa Monica , Breakthrough Device Program , David Geffen School Of Medicine , Varian Interventional Solutions , Drug Administration , Breakthrough Device Designation , Interventional Radiology , David Geffen School , Varian Interventional , Device Program ,